SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-22-172369
Filing Date
2022-06-13
Accepted
2022-06-13 06:11:43
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d368796d424b5.htm 424B5 431410
2 GRAPHIC g368796g04p10.jpg GRAPHIC 55333
3 GRAPHIC g368796g50g50.jpg GRAPHIC 52218
  Complete submission text file 0001193125-22-172369.txt   568876
Mailing Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140
Business Address 200 CAMBRIDGE PARK DRIVE SUITE 3100 CAMBRIDGE MA 02140 617-945-5576
Cogent Biosciences, Inc. (Filer) CIK: 0001622229 (see all company filings)

IRS No.: 465308248 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-264773 | Film No.: 221010658
SIC: 2834 Pharmaceutical Preparations